These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31639279)

  • 1. Late-onset hypogonadism: a concept comes of age.
    Nieschlag E
    Andrology; 2020 Nov; 8(6):1506-1511. PubMed ID: 31639279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical evaluation of different available guidelines for late-onset hypogonadism.
    Giagulli VA; Castellana M; Lisco G; Triggiani V
    Andrology; 2020 Nov; 8(6):1628-1641. PubMed ID: 32593233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-onset Hypogonadism: Bone health.
    Rochira V
    Andrology; 2020 Nov; 8(6):1539-1550. PubMed ID: 32469467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone replacement therapy.
    Barbonetti A; D'Andrea S; Francavilla S
    Andrology; 2020 Nov; 8(6):1551-1566. PubMed ID: 32068334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset hypogonadism: Prostate safety.
    Miranda EP; Torres LO
    Andrology; 2020 Nov; 8(6):1606-1613. PubMed ID: 32056383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
    Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
    Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset hypogonadism and lifestyle-related metabolic disorders.
    Braga PC; Pereira SC; Ribeiro JC; Sousa M; Monteiro MP; Oliveira PF; Alves MG
    Andrology; 2020 Nov; 8(6):1530-1538. PubMed ID: 31991053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Association of Urology Position Statement on the Role of the Urologist in the Management of Male Hypogonadism and Testosterone Therapy.
    Mirone V; Debruyne F; Dohle G; Salonia A; Sofikitis N; Verze P; Fode M; Chapple C;
    Eur Urol; 2017 Aug; 72(2):164-167. PubMed ID: 28249799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects.
    Schubert M; Jockenhövel F
    J Endocrinol Invest; 2005; 28(3 Suppl):23-7. PubMed ID: 16042356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment.
    Huhtaniemi I
    Asian J Androl; 2014; 16(2):192-202. PubMed ID: 24407185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
    Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
    J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversial aspects of testosterone in the regulation of sexual function in late-onset hypogonadism.
    Maggi M; Filippi S; Vignozzi L; Rastrelli G
    Andrology; 2020 Nov; 8(6):1580-1589. PubMed ID: 32248652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMAS position statement: Testosterone replacement therapy in the aging male‏.
    Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
    Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLOMIPHENE CITRATE IN THE TREATMENT OF IDIOPATHIC OR FUNCTIONAL HYPOGONADOTROPIC HYPOGONADISM IN MEN: A CASE SERIES AND REVIEW OF THE LITERATURE.
    Liel Y
    Endocr Pract; 2017 Mar; 23(3):279-287. PubMed ID: 27849376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflections on the T Trials.
    Swerdloff R; Wang C
    Andrology; 2020 Nov; 8(6):1512-1518. PubMed ID: 32902162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.
    Ko YH; Kim JJ
    Asian J Androl; 2011 Jul; 13(4):563-8. PubMed ID: 21572448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Hormone Testing for the Diagnosis and Evaluation of Male Hypogonadism and Monitoring of Testosterone Therapy: Application of Hormone Testing Guideline Recommendations in Clinical Practice.
    Muram D; Zhang X; Cui Z; Matsumoto AM
    J Sex Med; 2015 Sep; 12(9):1886-94. PubMed ID: 26272690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-dependent miR-125a-5p targets LYPLA1 and regulates global protein palmitoylation level in late-onset hypogonadism males.
    Qu M; Zhao Y; Qing X; Zhang X; Li H
    J Cell Physiol; 2021 Jun; 236(6):4738-4749. PubMed ID: 33284463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.